Mathieu Messager

Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation

Guillaume Piessen, Mathieu Messager, Emmanuelle Leteurtre et al. · Annals of Surgery · 2009 · 314 citations

The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma

Mathieu Messager, Jérémie H. Lefèvre, Virginie Pichot-Delahaye et al. · Annals of Surgery · 2011 · 201 citations

Is There a Role for Surgery for Patients with a Complete Clinical Response after Chemoradiation for Esophageal Cancer? An Intention-to-Treat Case-Control Study

Guillaume Piessen, Mathieu Messager, X. Mirabel et al. · Annals of Surgery · 2013 · 100 citations

Is signet-ring cell carcinoma a specific entity among gastric cancers?

Thibault Voron, Mathieu Messager, Alain Duhamel et al. · Gastric Cancer · 2015 · 79 citations · Full text

Tumor Biology, Esophageal Cancer, Gastrointestinal Oncology +7

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002

Guillaume Piessen, Mathieu Messager, Karine Le Malicot et al. · BMC Cancer · 2013 · 75 citations · Full text